Literature DB >> 15542517

Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls.

T O C Kilkens1, A Honig, M A van Nieuwenhoven, W J Riedel, R-J M Brummer.   

Abstract

BACKGROUND: Serotonin, a key denominator of the brain-gut axis, is involved in the regulation of gastrointestinal motility, secretion, and perception as well as cognition and mood. AIM: To assess the effects of an acutely lowered serotonin synthesis, using the acute tryptophan depletion (ATD) method, on visceral perception, affective memory performance, and mood in diarrhoea predominant irritable bowel syndrome patients (d-IBS) and controls.
METHODS: In a randomised, double blind, crossover design, 14 d-IBS patients and fourteen matched controls were studied under ATD and placebo conditions, respectively. Perception of urge and pain was scored during rectal distensions. Affective memory performance, mood, and biochemical parameters of serotonergic metabolism were simultaneously assessed.
RESULTS: ATD significantly decreased plasma tryptophan (67.0 (2.0) v 24.9 (2.0) mumol/l) and 5-hydroxyindole acetic acid concentrations (29.9 (1.0) v 15.8 (0.6) nmol/l). ATD was associated with significantly increased urge scores specifically in the lower pressure range and overall increased pain scores. ATD significantly lowered the perceptual threshold for first perception compared with placebo (patients 10.6 (1.2) v 13.6 (0.8) mm Hg, controls 12.6 (1.3) v 15.7 (1.2) mm Hg) but not for maximal tolerable discomfort (patients 50.5 (3.6) v 51.6 (3.3) mm Hg, controls 50.9 (3.3) v 48.8 (2.9) mm Hg). ATD induced a significant shift in affective memory bias towards preferential loss of positive material but no significant changes in mood. ATD did not differentially affect the patient or control group.
CONCLUSIONS: We have provided evidence that serotonergic modulation by ATD affects both visceral perception as well as cognition in d-IBS and controls. Simultaneous measurement of brain and gut function and the application of ATD contribute to the elucidation of the complex pathophysiology of IBS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542517      PMCID: PMC1774304          DOI: 10.1136/gut.2004.041657

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  Acute tryptophan depletion slows gastric emptying in females.

Authors:  Michiel A van Nieuwenhoven; Sabine D M Valks; Sjacko Sobczak; Willem J Riedel; Robert-Jan M Brummer
Journal:  Br J Nutr       Date:  2004-03       Impact factor: 3.718

2.  Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease.

Authors:  E A Walker; P P Roy-Byrne; W J Katon; L Li; D Amos; G Jiranek
Journal:  Am J Psychiatry       Date:  1990-12       Impact factor: 18.112

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography.

Authors:  D C Turnell; J D Cooper
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

Review 5.  Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications.

Authors:  N J Talley
Journal:  Aliment Pharmacol Ther       Date:  1992-06       Impact factor: 8.171

6.  Correlation of serotonin and monoamine oxidase levels with anxiety level in diarrhea-predominant irritable bowel syndrome.

Authors:  R K Singh; H P Pandey; R H Singh
Journal:  Indian J Gastroenterol       Date:  2003 May-Jun

7.  Selective affective biasing in recognition memory in the irritable bowel syndrome.

Authors:  J E Gomborone; P A Dewsnap; G W Libby; M J Farthing
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  A unique central tryptophan hydroxylase isoform.

Authors:  Diego J Walther; Michael Bader
Journal:  Biochem Pharmacol       Date:  2003-11-01       Impact factor: 5.858

9.  Self-schema in irritable bowel syndrome and depression.

Authors:  B B Toner; P E Garfinkel; K N Jeejeebhoy; H Scher; D Shulhan; I Di Gasbarro
Journal:  Psychosom Med       Date:  1990 Mar-Apr       Impact factor: 4.312

Review 10.  Basic and clinical aspects of visceral hyperalgesia.

Authors:  E A Mayer; G F Gebhart
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

View more
  24 in total

Review 1.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 2.  New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.

Authors:  Michael D Crowell; Lucinda Harris; Michael P Jones; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2005-08

3.  Fatty acid profile and affective dysregulation in irritable bowel syndrome.

Authors:  Tessa O C Kilkens; Adriaan Honig; Michael Maes; Richel Lousberg; Robert-Jan M Brummer
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

4.  Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women.

Authors:  J S Labus; E A Mayer; J Jarcho; L A Kilpatrick; T O C Kilkens; E A T Evers; W H Backes; R-J M Brummer; M A van Nieuwenhoven
Journal:  Gut       Date:  2011-03-14       Impact factor: 23.059

5.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527

6.  Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests I. Review of biochemical aspects and poor specificity of current amino Acid formulations.

Authors:  Abdulla A-B Badawy; Donald M Dougherty; Dawn M Richard
Journal:  Int J Tryptophan Res       Date:  2010-01-01

Review 7.  Bovine immunoglobulin protein isolates for the nutritional management of enteropathy.

Authors:  Bryon W Petschow; Anthony T Blikslager; Eric M Weaver; Joy M Campbell; Javier Polo; Audrey L Shaw; Bruce P Burnett; Gerald L Klein; J Marc Rhoads
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

8.  TPH gene polymorphisms are associated with disease perception and quality of life in women with irritable bowel syndrome.

Authors:  Sang-Eun Jun; Ruth Kohen; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2012-11-20       Impact factor: 2.522

Review 9.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

10.  Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.

Authors:  Gerard Clarke; Peter Fitzgerald; John F Cryan; Eugene M Cassidy; Eamonn M Quigley; Timothy G Dinan
Journal:  BMC Gastroenterol       Date:  2009-01-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.